Regulation 2

the date after which; or

the month and year after the end of which,as the case may be, the reagent or testing material should not be used;“General Regulations” means the Healthcare Services (General) Regulations 2021 (G.N. No. S 1035/2021);“imaging modality” means —

any imaging modality set out in paragraph 1(a) of Part 2 of the Schedule;

bone densitometry; or

ultrasound;“imaging service” means the use of ionising or non ionising radiation for any of the following purposes:

examination of the body, or any matter derived from the body, of an individual;

assessment of the health or condition of an individual;

observation and diagnosis of a condition, disability, disease, disorder or an injury of the body or mind of an individual;

determining, predicting or providing a prognosis of the health or condition of an individual;“laboratory discipline” means any laboratory discipline set out in paragraph 1(a) of Part 1 of the Schedule;“laboratory discipline” has the meaning given by regulation 4(4);“licence” means a licence under the Act authorising the licensee to provide an applicable service;“licensee” means a clinical laboratory service licensee or a radiological service licensee;“patient” —

in relation to a clinical laboratory service licensee, means the individual from whose body a specimen is derived for testing by or on behalf of the licensee; or

in relation to a radiological service licensee, means the individual for whom a radiological examination is performed by or on behalf of the licensee;“personnel”, in relation to a licensee, means any individual employed or engaged by the licensee to assist the licensee in providing the applicable service;“radioactive specimen” means any specimen —

on which a radioactive substance is applied for the purpose of a test or examination of the specimen; or

that is derived, obtained or excreted from an individual who was administered a radiopharmaceutical for the purpose of testing or examining the specimen, whether or not the specimen contains any radioactive substance;“radioactive substance” has the meaning given by section 2(1) of the Radiation Protection Act 2007;“radiological service” has the meaning given by paragraph 2 of the First Schedule to the Act;“radiological service licensee” means a person who holds a licence to provide a radiological service;“radiopharmaceutical” means any unsealed source (within the meaning given by regulation 2 of the Radiation Protection (Ionising Radiation) Regulations 2023 (G.N. No. S 85/2023)) that is administered to a patient as a diagnostic agent;“requestor”, in relation to a patient, means —

the medical practitioner, dentist or collaborative prescribing practitioner who ordered a test or radiological examination for the patient; or

any person who is approved by the Director-General to request a licensee to conduct a test for the patient without a referral by a medical practitioner, dentist or collaborative prescribing practitioner;[Deleted by S 417/2023 wef 26/06/2023][Deleted by S 417/2023 wef 26/06/2023][Deleted by S 417/2023 wef 26/06/2023]“simple in vitro diagnostic test” has the meaning given by paragraph 2 of the First Schedule to the Act;“specimen” has the meaning given by regulation 2 of the General Regulations;“temporary premises” means any premises other than permanent premises;“test” means an analysis or examination of a specimen conducted by a licensee in connection with the provision of a clinical laboratory service;“testing material” means any test kit, material, device, equipment, instrument or other article that is used to conduct a simple in vitro diagnostic test;“testing service” means the examination or testing of any matter derived, obtained or excreted from the body of any individual for the purpose of —

assessing the health or genetic predisposition of that individual or any other individual;

predicting or providing a prognosis of the health condition of that individual or any other individual;

diagnosing a condition, disability, disease, disorder or an injury of the body or mind of that individual or any other individual;

determining the intervention to be taken, or the effect of any intervention taken, of a condition, disability, disease, disorder or an injury of the body or mind of an individual;

ascertaining the result of a medical or surgical treatment given to that individual or any other individual; or

assessing the health, condition or suitability of any human biological material that is used, or is intended to be used, in relation to any healthcare service.